Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Gnrh Antagonist

Related Conditions

Often studied with 16 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Phase 1/2 (1)

Trial Status

Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT04661072RecruitingPrimary

Congenital Uterine Anomalies: Identifying Cancer Associations and Genetic and Environmental Factors to Improve Clinical Care

NCT04071574Phase 1/2Completed

Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility

Showing all 2 trials

Research Network

Common Treatments

  • Gnrh Antagonist1
  • Gnrha Triptorelin1
  • Gonadotropins1
  • Human Chorionic Gonadotropin Hcg1

Active Sponsors

  • Lebanese University1
  • Yale University1
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1

Top Investigators

Related Conditions

  • Salpingitis1
  • Polycystic Ovary Syndrome1
  • Female Infertility Endocrine1
  • Female Infertility1
  • Fibroids1

Activity Timeline